Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Book Building - SME
₹ -
₹ -
-
₹ -
BSE - SME
-
-
-
Initial public issue of upto 23,00,000 equity shares of face value of Rs. 10/- each of Speciality Medicines Limited (SMCL or the Company or the Issuer) for cash at a price of Rs. [*]/- per equity share including a share premium of Rs. [*]/- per equity share (the Issue Price) aggregating to Rs. [*] crores (The Issue), of which [*] equity shares of face value of Rs. 10/- each for cash at a price of Rs. [*]/- per equity share including a share premium of Rs. [*]/- per equity share aggregating to Rs. [*] crores will be reserved for subscription by market maker to the issue (the Market Maker Reservation Portion). The issue less the market maker reservation portion i.e. net issue of [*] equity shares of face value of Rs. 10/- each at a price of Rs. [*]/- per equity share including a share premium of Rs. [*]/- per equity share aggregating to Rs. [*] crores is herein after referred to as the Net Issue. The issue and the net issue will constitute [*]% and [*]%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each. The price band and the minimum bid lot will be decided by the company.
Setting up of Research & Development (R&D) Center. Product registration in the international markets. Repayment/prepayment in full or part of certain borrowings availed by the company. To meet working capital requirements. General corporate purposes.
Speciality Medicines Ltd, D-153/A 1st Flr, Okhla Industrial Are, Phase-I, New Delhi-110020
Phone - 91-11-26812682
Fax - 91-11-30857562
Email - investors.grievances@specialitymedicaine.com
Website - www.specialitymedicine.com